Gold nanoparticles coated with oligomannosides of HIV-1 glycoprotein gp120 mimic the carbohydrate epitope of antibody 2G12 |
| |
Authors: | Marradi Marco Di Gianvincenzo Paolo Enríquez-Navas Pedro M Martínez-Ávila Olga M Chiodo Fabrizio Yuste Eloísa Angulo Jesús Penadés Soledad |
| |
Affiliation: | 1 Laboratory of GlycoNanotechnology, Biofunctional Nanomaterials Unit, CIC biomaGUNE, Paseo Miramón 182, E-20009 San Sebastián, Spain2 Biomedical Research Networking Center in Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), Paseo Miramón 182, E-20009 San Sebastián, Spain3 Retrovirology and Viral Immunopathology Laboratory, IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain4 HIVACAT, Hospital Clínic, Faculty of Medicine, University of Barcelona, Barcelona, Spain5 Department of Bioorganic Chemistry, Instituto de Investigaciones Químicas (CSIC-US), Américo Vespucio 49, E-41092 Sevilla, Spain |
| |
Abstract: | After three decades of research, an effective vaccine against the pandemic AIDS caused by human immunodeficiency virus (HIV) is not still available, and a deeper understanding of HIV immunology, as well as new chemical tools that may contribute to improve the currently available arsenal against the virus, is highly wanted. Among the few broadly neutralizing human immunodeficiency virus type 1 (HIV-1) monoclonal antibodies, 2G12 is the only carbohydrate-directed one. 2G12 recognizes a cluster of high-mannose glycans on the viral envelope glycoprotein gp120. This type of glycan has thus been envisaged as a target to develop an HIV vaccine that is capable of eliciting 2G12-like antibodies. Herein we show that gold nanoparticles coated with self-assembled monolayers of synthetic oligomannosides [manno-gold glyconanoparticles (GNPs)], which are present in gp120, are able to bind 2G12 with high affinity and to interfere with 2G12/gp120 binding, as determined by surface plasmon resonance and saturation transfer difference NMR spectroscopy. Cellular neutralization assays demonstrated that GNPs coated with a linear tetramannoside could block the 2G12-mediated neutralization of a replication-competent virus under conditions that resemble the ones in which normal serum prevents infection of the target cell. Dispersibility in water and physiological media, absence of cytotoxicity, and the possibility of inserting more than one component into the same nanoparticle make manno-GNPs versatile, polyvalent, and multifunctional systems that may aid efforts to develop new multifaceted strategies against HIV. |
| |
Keywords: | HIV, human immunodeficiency virus HIV-1, human immunodeficiency virus type 1 GNP, gold glyconanoparticle mAb, monoclonal antibody SPR, surface plasmon resonance STD, saturation transfer difference GlcC5S, 5-(thio)pentyl β- smallcaps" >d-glucopyranoside RU, response unit PBS, phosphate-buffered saline |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|